Sample
Human Serum or Plasma (citrate, heparin)
Intended Use
Enzyme immunoassay for the qualitative determination of IgG class antibodies against Parainfluenza virus (Type 1, 2 and 3) in human serum or plasma (citrate, heparin).
Contents of Kit
Enzyme immunoassay for the qualitative determination of IgG class antibodies against Parainfluenza virus (Type 1, 2 and 3) in human serum or plasma (citrate, heparin).
Storage
Store the kit at 2 - 8°C. The opened reagents are stable up to the expiry date stated on the label when stored at 2 - 8°C.
Performance Characteristics
The results refer to the groups of samples investIgGted; these are not guaranteed specifications.
The diagnostic sensitivity is defined as the probability of the assay of scoring positive in the presence of the specific analyte. It is 100% (95% confidence interval: 59.04 % - 100 %).
The diagnostic specificity is defined as the probability of the assay of scoring negative in the absence of the specific analyte. It is 100% (95% confidence interval: 87.23 % - 100 %).
General Description
Parainfluenza viruses are important viral pathogens causing upper and lower respiratory infections in adults and children. The viruses belong to the family of Paramyxoviridae. They are enveloped single-stranded RNA viruses with spherical or pleomorphic shape. Parainfluenza viruses are relatively large viruses of about 150 - 300 nm in diameter. On the basis of antigenic differences they are divided into four subtypes, of which type 4 is divided into two subtypes. Parainfluenza virus 1 and 3 belong to the paramyxovirus genus. Parainfluenza virus 2, 4a and 4b belong to the rubella virus genus along with mumps. The virus is ubiquitous; infections occur as epidemics as well as sporadically. Parainfluenza viruses are sensitive to detergents and heat but can remain viable on surfaces for up to 10 hours. Transmission occurs via droplets, aerosols and fomites (viruses survive on surfaces). Parainfluenza virus infections are primarily childhood diseases, the highest age-specific attack rates for croup occur in children below the age of 3 years. Type 3 infections occur earliest and most frequently, so that ~50% of children are infected during the first year of life and almost all by 6 years, as determined by seroepidemiological studies. Antibodies against types 1 and 2 are acquired less rapidly but 80% of children have antibodies by 10 years of age. Type 4 viruses induce few clinical illnesses but infections are common, 70 - 80% of children have antibodies by 10 years of age. In all age groups, the incubation period appears to be five to six days. Croup or laryngotracheobronchitis is the commonest clinical manifestation of infection. Parainfluenza viruses are found uncommonly associated with other respiratory tract infections in children such as tracheobronchitis, bronchiolitis, and bronchopneumonia. Occasionally, a mild non-specific illness is seen after parainfluenza virus infection. In adults, the virus is usually limited to causing inflammation in the upper parts of the respiratory tract.
Infection or presence of pathogen may be identified by:
1.Microscopy
2.PCR
3.Serology: e.g. ELISA
Citations
Publication ()
Have you cited DEIA1948 in a publication?
Let us know and earn a reward for your research.